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Ethnopharmacological relevance: Hymenaea stigonocarpa Mart. ex Hayne (Fabaceae) is a medicinal
species commonly found in the Brazilian savannah. The stem bark of this medicinal plant, popularly
known as ‘‘jatoba´-do-cerrado’’, is widely used in tea form to treat gastric pain, ulcers, diarrhoea and
inﬂammation, whereas its fruits pulp is edible.
Aim of the study: The aim of this study was to investigate the antidiarrheal and anti-ulcer effects of
a methanolic extract derived from the stem bark (MHs) and diet with fruit pulp of H. stigonocarpa.
Materials and methods: The antidiarrheal action of MHs was measured against the intestinal motility
and diarrhoea induced by castor oil in mice. The preventive action of MHs (50, 100, 150 and 200 mg/Kg,
by oral route (p.o.)) against peptic ulcers was evaluated in experimental rodent models challenged with
absolute ethanol, non-steroidal anti-inﬂammatory drugs (NSAIDs), ischemia–reperfusion (I/R) (200mg/Kg,
p.o.) and cysteamine (200mg/Kg, p.o.). The main anti-ulcer mechanisms of action of MHs were analysed as
follows: evaluation of the gastric juice parameters, assessment of mucus adherence to the gastric wall,
determination of the role of nitric oxide (NO) and sulfhydryl compounds (SH), glutathione (GSH) levels and
myeloperoxidase (MPO) activity. The healing effects from MHs (200 mg/Kg) and diet with fruit pulp (10%)
against gastric and duodenal ulcers induced by acetic acid were also evaluated by treating rats over 7 or 14
consecutive days of treatment.
Results: The phytochemical proﬁle of MHs and fruit pulp indicated the presence of phenolic compounds
(mainly ﬂavonoids and condensed tannins). MHs (200 mg/Kg, p.o.) displayed an antidiarrheal effect and were
able to protect gastric mucosa against absolute ethanol (68% protection) and also against the injurious effect
of NSAIDs (86% protection) when compared to the group treated with vehicle. These results were
accompanied by the prevention of GSH depletion and an inhibition of MPO activity when compared to
animals treated with vehicle (Po0.05). MHs markedly protected duodenal mucosa against injuries caused by
cysteamine (98%) and also against I/R induced gastric ulceration (80%) when compared to the group treated
with vehicle. Furthermore, MHs also prevented the GSH depletion of gastric mucosa relative to the control
group treated with vehicle. NO appeared to be involved in this gastroprotective effect. MHs and diet with fruit
pulp clearly demonstrated gastric healing actions after treatment for 7 (MHs – 53% inhibition) or 14 days
(MHs – 60% inhibition and fruit pulp – 61% inhibition). Treatment with diet with fruit pulp for 7 days
demonstrates a signiﬁcant duodenal healing effect (71% inhibition) without any signs of toxicity.
Conclusions: MHs clearly demonstrate antidiarrheal, gastroprotective and cicatrising effects in experimental
gastric and duodenal ulcers, and the diet with fruit pulp displays duodenal healing effects. The observed
effects may be associated with the antioxidant effect, which may be due the presence of condensed tannins
and ﬂavonoids in the bark and fruit of H. stigonocarpa.
& 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.x: þ55 1438153744.
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Peptic ulcer affects 10% of the world population (Zapata-
Colindres et al., 2006). Despite great advances in our under-
standing of this disease, its aetiology has not been completely
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disease remains incomplete (Glavin and Szabo, 1992). The peptic
ulcer result of an imbalance between aggressive factors, such as
acid–pepsin secretion, and protective mechanisms of the sto-
mach, such as the mucosal barrier, mucus secretion, and cell
regeneration (Klein et al., 2010). Among various causes of peptic
ulcers, lesions due to stress, alcohol consumption, Helicobacter
pylori infection and the use of non-steroidal anti-inﬂammatory
drugs have all been shown to be mediated largely through the
generation of reactive oxygen species, especially hydroxyl radicals
(–OH) (Bandyopadhyay et al., 2002). On the other hand, the
mucosal integrity is maintained by protective mechanisms, which
include pre-epithelial factors, an epithelial ‘‘barrier’’, continuous
cell renewal via proliferation of progenitor cells, continuous blood
ﬂow through mucosal microvessels, an endothelial ‘‘barrier’’,
sensory innervation, and the generation of prostaglandins and
nitric oxide (Laine et al., 2008).
Although many synthetic drugs are available to treat peptic
ulcers, most of these drugs have adverse reactions when used
long-term (Bandyopadhyay et al., 2002). For this reason, our
laboratory has been interested in studying the potential protec-
tive effects afforded by natural compounds against peptic ulcers,
and special interest was devoted to Hymenaea stigonocarpa Mart.
ex Hayne. H.stigonocarpa (Fabaceae) is a large tree popularly
known as ‘‘jatoba´-do-cerrado’’ that commonly grows in the
Brazilian savannah. Phytochemical studies to date from different
parts of the Hymaenea plant have demonstrated the presence of
sesquiterpenes (Langenheim and Hall, 1983; Aguiar et al., 2010),
fatty acids (Matuda and Netto, 2005), diterpenes (Khoo et al.,
1973; Cunningham et al., 1973; Cunningham et al., 1974;
Marsaioli et al., 1975; Nogueira et al., 2001; Abdel-Kader et al.,
2002), and oligosaccharides (Lima et al., 1995). According to
ethnopharmacological data, the stem bark and fruit of H. stigonocarpa
are used in Brazilian folk medicine for the treatment of gastric pain,
ulcers, diarrhoea, and as an anti-inﬂammatory (Grandi et al., 1989).
The stem bark, fruit, sap and resin of H. stigonocarpa are used in folk
medicine in the following forms: decoction, syrup, infusion, sap,
poultice, ointment or wine (Grandi et al., 1989). The fruit pulp of H.
stigonocarpa is also consumed in regional cuisine and the ﬂour used
fresh for the preparation of cakes, breads, cookies and hot cereal (Silva
et al., 2001). However, despite the ethnopharmacological indications
from this medicinal species, there is no pharmacological evidence for
their effects in the gastrointestinal tract (for either ulcers or diar-
rhoea). In this context, the aim of the present work was to investigate
the antidiarrheal action of this species and the protective and healing
effects of a methanolic extract of the bark of H. stigonocarpa and its
fruit pulp on gastric and duodenal ulcers.2. Materials and methods
2.1. Drugs and chemicals
Chemicals were of analytical grade and were purchased from
Sigma Chemical Co. (St. Louis, USA): absolute ethanol (Sinth, Brazil),
lansoprazole (Cruz Vermelha, Brazil), N-nitro-L-arginine methyl ester
(L-NAME), indomethacin, carbenoxolone, cimetidine, N-ethylmalei-
mide (NEM), Alcian Blue, cysteamine hydrochloride, histamine, castor
oil, morphine, loperamide, methanol, hexadecyltrimethylammonium
bromide, trichloroacetic acid, NaH2PO4, Na2HPO4, ferrous sulphate,
ascorbic acid, thiobarbituric acid, quercetin, ketamine hydrochloride,
xylazine hydrochloride, acetic acid and NaOH.
HPLC-grade solvents were obtained from Tedia Company
(Phillipsburg, USA). Deionised water (18 MO cm) was puriﬁed
in house using a Milli-Q puriﬁcation system (Millipore Co.,
Bedford, USA).2.2. Plant material
The stem barks and fruits of H. stigonocarpa (Hs) were
collected in savannah areas near Botucatu city, S~ao Paulo State,
in March 2009 by Dr. Leonardo Noboru Seito. Authentication was
by the botanist Prof. Dr. Osmar Cavassan. A voucher specimen has
been deposited at the Herbarium located at Unesp-Bauru (UNBA
number 5691), Brazil.2.3. Preparation of extracts
After collection, the stem barks were dehydrated, stabilised
on an air circulation chamber at 50 1C for 48 h and then milled
by a mechanical grinder. The air-dried powdered barks of Hs
(1545 g) were exhaustively extracted with methanol (48 h, 1.5 L,
three times) at room temperature. Solvents were evaporated at
40 1C under reduced pressure to yield 118.76 g of the methanolic
extract of H. stigonocarpa (7.6%) (MHs). For the preparation of
the fruit ﬂour, fruits were opened to gather the pulp and the
seeds rejected. Then, the pulp was dehydrated and stabilised on
an air circulation chamber at 40 1C for 24 h. After drying, pulp
residue was powdered in a knife mill and sequentially mixed
with normal feed Labina-Purine up to 10%, using water as a
vehicle. The mixture was automatically pelletised and dried in
an air circulation chamber at 40 1C for 48 h. Fingerprints of stem
barks and fruits were complementary determined by means of
high performance liquid chromatography coupled to photodiode
array detection (HPLC–PAD). An aliquot (20 mg) of the bark
extract and another one from theof fruit were dissolved in
methanol (400 mL) in an ultrasonic bath for 1 min and submitted
to clean-up by solid phase extraction. Samples were loaded onto
an Agilent SampliQ RP18 cartridge (11.1 cm d.i.) eluted with
1600 mL of methanol. The eluents were ﬁltered through a
0.45 mm polytetraﬂuoroethylene (PTFE) membrane ﬁlter and
stored in amber vials. The analyses were performed on a HPLC-
PAD Jasco system equipped with a PU-2089 quaternary pump,
an MD-2010 Plus Photodiode Array Detector, and an AS-2055
Plus autosampler. Separations were achieved with a Phenom-
enex Synergi Hydro column (C18, 2504.6 mm d.i., 4 mm)
equipped with a Phenomenex security guard (C18, 43 mm d.i.).
The mobile phase was composed of acetonitrile (eluent A) and
water (eluent B), both acidiﬁed with 0.1% triﬂuoroacetic acid. The
mobile phase ranged from 10–23% of B in 35 min to 23–90% of B in
50 min at a ﬂow rate of 1 ml min1. The software EZCrom Elite
version 3.1.7 (Agilent Technologies) was used for data acquisition
and processing.2.4. Animals
Male and female Swiss mice (25–35 g) and male Wistar rats
(150–250 g) from the Central Animal House of the UNESP were
used. The animals were fed with a certiﬁed Labina-Purine diet,
with free access to tap water, under standard conditions of 12 h
dark-12 h light cycle, humidity (6071.0%) and temperature
(2171 1C). The animals were fasted before all experimental
procedures. Standard drugs and MHs (bark) were administered
orally (gavage) using a saline solution (10 mL/Kg) as the vehicle,
whereas fruit ﬂour was added to the diet as food. The animals
were housed in cages with raised ﬂoors made of wide mesh to
prevent coprophagy. All experiments were performed in the
morning and followed the recommendations of the Canadian
Council on Animal Care (Olfert et al., 1993). The UNESP Institu-
tional Animal Care and Use Committee approved all of the
employed protocols (42/04-CEEA).
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Additional in vitro experiments were performed to evaluate
the antioxidant activity of different concentrations of MHs (1.14–
145.45 mg/ml). This in vitro test was evaluated using a thiobarbi-
turic acid-reactive species (TBARS) assay (Witaicenis et al., 2010)
modiﬁed from the original protocol described by Stocks et al.
(1974). Brieﬂy, rat brain samples were obtained from two-month-
old male Wistar rats. Tissue samples were homogenised 1:4 (w/v)
in buffer containing 19 parts of NaH2PO4 (10 mM) and 81 parts of
Na2HPO4 (10 mM) (pH 7.4) to obtain membrane supernatant after
centrifugation (22,176 g/15 min/4 1C). This membrane suspen-
sion was diluted 1:10 (v/v) in the above-mentioned buffer
solution. Next, buffers (in the assays without inhibitors) or
different concentrations of MHs were added. Lipid peroxidation
was non-enzymatically induced with 100 mol/L of both ferrous
sulphate and ascorbic acid. After incubation at 37 1C for 12 min,
the reaction was stopped and malondialdehyde (MDA) deter-
mined by 0.5% thiobarbituric acid reaction in 20% trichloroacetic
acid. Measurement of the absorbance of the supernatants was
read at 532 nm. The resultant products of the thiobarbituric acid
reaction were taken as indicators of lipid peroxidation in mem-
brane fractions. The ﬂavonoid quercetin was used as a reference
and tested in the same assay system.
2.6. Acute toxicity and hippocratic screening
Male and female Swiss mice were randomly divided into
groups (n¼10) that orally received saline solution (10 mL/Kg) or
MHs at the same dose of 5000 mg/Kg. After oral administration,
the acute toxicity and behavioural parameters were described
according to the methods of Souza Brito (1994). The observations
were performed at 30, 60, 120, 240 and 360 min after the oral
treatments. For 14 days, the animals were weighed and the
number of deaths noted. On the 14th day, mice were sacriﬁced
and the heart, liver, kidney, lung, spleen, testicles (male), ovaries
and uterus (female) collected. We compared all parameters from
animals treated with MHs with those obtained from the respec-
tive control group treated with vehicle (saline).
2.7. Gastrointestinal motility in mice
Male Swiss mice (n¼7) were weighed and deprived of food for
6 h, but they had free access to water. At time zero, the animals
received vehicle (saline) as the negative control, 2.5 mg/Kg of
morphine as the positive control or MHs at doses of 100, 150 and
200 mg/Kg by oral gavage. Thirty minutes after treatment, all
groups received activated charcoal (0.1 mL/10 g, orally) and were
sacriﬁced 30 min later. The results were expressed as a percen-
tage of the total length of the small intestine. The distance
travelled by the charcoal relative to the total length of the small
intestine was calculated for each mouse to express the percentage
of distance travelled and converted by arcosin (Stickney and
Northup, 1959, with modiﬁcations).
2.8. Diarrhoea induced by castor oil
Five groups of male Swiss mice (n¼7) were orally treated with
vehicle saline (10 mL/Kg), MHs (100, 150 and 200 mg/Kg) or
loperamide (5 mg/Kg) 30 min before castor oil (0.2 mL/animal)
administration. Immediately after ingesting castor oil, each ani-
mal was kept in an individual cage with a ﬂoor lined with blotting
paper and observed for 5 h. The following parameters were
monitored: time to initial evacuation (min), evacuation classiﬁca-
tion: 1 (normal stool), 2 (semi-solid stool), and 3 (watery stool)
and evacuation index (EI), expressed according to the followingformula: eI¼1 (no stool 1)þ2 (no stool 2)þ3 (no stool 3)
(Awounters, 1978, modiﬁed by Mukherjee et al., 1998).
2.9. Evaluation of the lesions
Based on their respective speciﬁcations, the groups under each
experimental model included positive (carbenoxolone, lanzopra-
zole or cimetidine) and negative (vehicle–saline) controls. More-
over, the animals were kept in cages with raised ﬂoors of wide
mesh to prevent coprophagy. After each experiment the animals
were euthanized with CO2 gas, the stomachs are excised, cut
along the greater curvature, and gently rinsed und tap water
pressed onto a glass plate, and scanned so that the lesions could
be counted with aid of the AVSoft program. The results were
expressed as total ulcerated area (mm2).
2.10. Evaluation of gastroprotective activity
Ethanol-induced ulcers—This experiment was performed as
described by Morimoto et al. (1991) and Glavin and Szabo
(1992). Male albino Wistar rats were randomly distributed into
6 groups (n¼8) and fasted for 18 h prior to receiving an oral dose
of the vehicle (saline; 10 mL/Kg), lansoprazole (30 mg/Kg) or MHs
(50, 100, 150 or 200 mg/Kg body weight). After 60 min, all groups
were treated orally with 1 mL of absolute ethanol to induce
gastric ulcers. According to Glavin and Szabo (1992), the ulcers
can be examined 1–2 h after ethanol administration. Time course
studies revealed that most gastric damage. After another 1 h, the
animals were sacriﬁced, and the extent of the lesions was
measured by AvSofts Bioview Spectra, Brazil. The lesion mea-
surements were expressed as mm2.
NSAID-induced gastric ulcers in rat—In this model (Guidobono
et al., 1997 with modiﬁcations), gastric lesions were induced with
indomethacin (50 mg/Kg, p.o.) administered to male Wistar
albino rats (n¼8) after an 18 h fast. MHs (50, 100, 150 or
200 mg/Kg body wt.), cimetidine (100 mg/Kg) or vehicle was
orally administered 30 min before the induction of the gastric
lesions. The animals were sacriﬁced 6 h after treatment with the
ulcerogenic agent. The stomachs were removed, and gastric
lesions were measured as described above.
Determination of Gastric Secretion—The assay was performed
according to the method of Shay et al. (1945) with a few
modiﬁcations. Male Wistar albino rats (n¼10) were randomly
divided into three groups and fasted for 18 h with free access to
tap water. The determination of gastric secretion was performed
by two routes as follows: oral route: thirty minutes after oral
administration of MHs (200 mg/Kg, which is the dose that
provided the best gastroprotective results), cimetidine (100 mg/Kg)
as a positive control or vehicle (saline, 10 mL/Kg), pylorus ligature
was performed as described by Shay et al. (1945). Intraduodenal
route: all groups of male rats (n¼10) were fasted for 18 h with
free access to water. Immediately after pylorus ligature, MHs
(200 mg/Kg), cimetidine (100 mg/Kg) or saline (10 mL/Kg) was
administered by an intraduodenal route. One hour after the
ligature, all animals received histamine (100 mg/Kg) subcuta-
neously. All animals were sacriﬁced 4 h later, the stomachs
removed, the gastric lesions measured (mm2), and the gastric
content collected to determine the total amount of gastric juice
acid (mL) and pH values (unit). Distilled water was added until a
10 mL volume was reached, and the resultant solution was
centrifuged at 3.000 g for 10 min. Total acid in the gastric
secretion volume was determined in the supernatant by titration
to pH 7.0 with 0.01 N NaOH (mEq/mL/4 h).
Assessment of mucus adhered to the gastric wall—The procedure
was performed according to the methods described by Come et al.
(1974) and modiﬁed by Rafatullah et al. (1990). After fasting for
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physis for the pylorus ligature in anaesthetised rats (n¼8).
Vehicle (saline; 10 mL/Kg), carbenoxolone (200 mg/Kg) or MHs
(200 mg/Kg) was orally administered for 1 h before the ligature.
Four hours later, the animals were sacriﬁced and the glandular
portion of the stomach separated, weighed and immersed in
a solution of Alcian Blue to quantify the mucus. For each sample,
the absorbance at 598 nm was measured in a spectrophotometer,
and the results are expressed as mg of Alcian blue/g of tissue.
Ethanol-induced gastric lesions in L-NAME- and NEM-pretreated
rats—The procedure was performed according to the methods
described by Matsuda et al. (1999). Gastric mucosal lesions were
induced in male Wistar rats (n¼7). Male Wistar rats fasted for
18 h were randomly divided into nine groups, three of which each
received saline (i.p.), 70 mg/Kg of NO synthase inhibitor (L-NAME)
or 10 mg/Kg of sulphydryl depleter (NEM). Thirty minutes after
the pretreatment, the oral treatments were applied (saline,
carbenoxolone 100 mg/Kg or MHs 200 mg/Kg). Sixty minutes
later, 1 mL of absolute ethanol was given to each rat; all animals
were sacriﬁced after 1 h. The stomachs were removed to deter-
mine gastric lesion areas (mm2).
Acute gastric mucosal lesions induced by ischemia-reperfusion in
rats—Ischemia–reperfusion (I/R) erosions were produced in three
groups of rats (n¼10) using the method originally proposed by
Ueda et al. (1989). The rats were deprived of food for 18 h before
the experiments but allowed access to tap water ad libitum.
Brieﬂy, under anaesthesia (0.08 mL/100 g of ketamine hydro-
chloride and 0.04 mL/100 g xylazine hydrochloride), the celiac
artery was clamped with a small clamp for 30 min. Then, the
clamp was removed, and reperfusion occurred for 60 min. Vehicle
(saline, 10 mL/Kg), lansoprazole (30 mg/Kg) or MHs (200 mg/Kg)
was administered orally 60 min prior to the experiments. The
untreated group comprised animals that were submitted to
the abdominal incision but not to I/R. After 60 min of reperfusion,
the animals were sacriﬁced and their stomachs excised for bio-
chemical determinations. The gastric mucosal injury was measured
by AvSofts Bioview Spectra (Brazil) and expressed as mm2.
2.11. Evaluation of the preventive effect of MHs on duodenal ulcers
in rats
Cysteamine duodenal ulcer in rats—Duodenal ulcers were
induced in male albino Wistar rats by two oral administrations
of cysteamine hydrochloride (400 mg/Kg) in saline solution at an
interval of 4 h. MHs (200 mg/Kg), lansoprazole (30 mg/Kg) or
vehicle (saline; 10 mL/Kg) was administered 30 min before the
ﬁrst dose of cysteamine. One untreated group was used to
evaluate the normal parameters of the duodenum mucosa. All
animals were sacriﬁced 48 h after the ﬁrst dose of cysteamine.
Each duodenum was cut open along the antimesenteric side and
rinsed with saline. The duodenal score was determined using the
following 4-point scale: 0¼no lesion, 1¼superﬁcial mucosal
erosion, 2¼deep ulcer or transmural ulcer, and 3¼perforated
or penetrated ulcer (Szabo, 1978). The macroscopic duodenal
area was recorded using AvSofts Bioview Spectra (Brazil) and
expressed as mm2.
2.12. Evaluation of curative effect of MHs and fruit pulp
of Hymenaea stigonocarpa (Hs) in the gastric and duodenal
ulcers induced by acetic acid in rats
The experiments were performed according to the method
described by Okabe et al. (1971) and modiﬁed by Konturek et al.
(1988). Gastric mucosal and duodenal lesions were induced in
male albino Wistar rats (n¼8) that were fasted for 18 h but had
free access to water. An incision was made in the abdomen ofanimals under anaesthesia, and a plastic mould (4.2 mm in
diameter) was placed tightly on the stomach in the ﬁrst experi-
ment and serosal surface of the duodenal wall; the mould was
approximately 5 mm distal to the pylorus in the second experi-
ment. Acetic acid (80%, 70 ml) was poured into the mould and
allowed to remain for 20 s on the stomach and 10 s on the
duodenal wall. The stomach and duodenum were bathed with
saline (20 1C) to remove the acetic acid. The abdomen was then
closed, and all of the animals were fed normally. The animals
were treated for 7 or 14 consecutive days beginning one day after
surgery. MHs (200 mg/Kg), lansoprazole (30 mg/Kg) or saline
were administered orally and the fruit ﬂour in the diet (10%)
was placed in a cage as food (40 g daily for monitoring the
consumption, in individual boxes). On the day after the last
administration, the rats were sacriﬁced and their stomachs and
duodenum removed. Body weight and food consumption were
assessed throughout the experiment. The gastric and duodenal
lesions were evaluated by examining the inner gastric and
duodenal surfaces with a dissecting magnifying glass. The macro-
scopic images of the gastric and duodenal ulcers were recorded
using AvSofts Bioview Spectra (Brazil) and expressed as mm2.
2.13. Evaluation of Hymenaea stigonocarpa subacute toxic activity
We evaluated the subacute toxic activity of these substances in
groups of rats treated with MHs and diet with fruit pulp (Hs)
(10%). Animals were subjected to daily treatment with MHs and
Hs (10%) for 14 days after induction of injury with acetic acid. The
parameters studied were body weight and macroscopic analysis
of the vital organs: heart, lungs, liver, spleen and kidneys. In
addition, the blood of the animals was collected for analysis of
biochemical and enzyme parameters, including serum gamma-GT
(gamma glutamyltransferase), urea, creatinine, AST (aspartate
aminotransferase), ALT (alanine aminotransferase) and glucose.
Analyses were quantiﬁed using the SBA-200 automatic biochem-
ical analyser and CELMs kinetics and colourimetric kits (Brazil)
available for use by the Clinical Analysis laboratory of the
Veterinary Hospital of the Faculty of Veterinary Medicine and
Animal Science of Unesp, Botucatu, under the guidance of Prof a.
Dr. Regina Kiomi Takahira.
2.14. Biochemical determinations from gastric and duodenal mucosa
Myeloperoxidase (MPO) activity was measured according to
the technique described by Krawisz et al. (1984). Samples were
suspended in 1 ml of 50 mM phosphate buffer incorporating 0.5%
hexadecyltrimethyl-ammonium bromide (pH 6.0) and minced
with scissors for 15 s on an ice-cold plate. The resultant suspen-
sion was subsequently diluted to a ﬁnal 1:20 (w/v) ratio and
homogenised for 1 min with an automatic Heidolph homogeniser,
then sonicated for 10 s and subjected to three freeze–thaw cycles.
The homogenates were then centrifuged at 7000 g and 4 1C for
10 min, and the supernatants were assayed for MPO activity.
The results are expressed as MPO units per gram (U/g) of wet tissue.
Total glutathione content (GSH) was quantiﬁed with the recy-
cling assay described by Anderson (1985). Samples were thawed,
minced, diluted 1:20 (w/v) in ice-cold 5% (w/v) trichloroacetic acid
and homogenised. The homogenates were centrifuged at 7000 g
for 15 min at 4 1C, and the supernatants were used to quantify
GSH. The results are expressed as nanomoles per gram (nmol/g) of
wet tissue.
2.15. Statistical analysis
The results were expressed as the mean7S.E.M., and the
differences between groups were determined by analysis of
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the Dunnett post-test (for three or more groups) or, for non-
parametric results, the Kruskal–Wallis test followed by Dunn’s
test; Po0.05 considered to be statistically signiﬁcant.3. Results and discussion
Acute toxicological studies have showed that an oral admin-
istration of 5000 mg/Kg of H. stigonocarpa methanolic stem bark
extract (MHs) did not produce any sign of acute toxicity in the
animals (male and female). Over the 14 days following the oral
administration of MHs, none of the animals died and no signiﬁ-
cant changes in daily body weight or organ weight were observed
through the end of this period (data not shown). These results
ensured the continuance of pharmacological studies on this
species using the oral route and motivated us to proceed with
the biological assays.
Based on ethnopharmacological data of the antidiarrheal
effects of H. stigonocarpa bark (Grandi et al., 1989) and the fact
that intestinal motility affects the luminal absorption and reg-
ulates the bioavailability of an orally administered drug (Lee et al.,
2000), we evaluated the effect of MHs on diarrhoea and on
intestinal motility. All mice from the control group (treated with
vehicle) produced copious diarrhoea after castor oil administra-
tion (Table 1). However, pre-treatment with MHs (100, 150 and
200 mg/Kg) induced a signiﬁcant delay in the onset of the copious
diarrhoea (61, 50 and 53%, respectively, relative to the vehicle)Table 1
Effects of methanolic extract of Hymenaea stigonocarpa of the bark (MHs) on antidiarrh
Treatment (p.o.) Dose (mg/kg) N Time to initial
evacuation (min)
Evacuatio
Normal
Vehicle – 7 59.6677.30 0.5070.34
Loperamide 5 7 228.14711.85nn 0.207020
MHs 100 7 77.14714.73 1.0070.31
150 7 114.83718.51n 0.5070.22
200 7 113.2875.93n 1.0070.22
Data are presented as mean7S.E.M. ANOVA was employed, followed by Dunnett’s test,
vs control group treated with vehicle. For classiﬁcation of evacuations and calculation
a Inhibition in relation to evacuation index.
n Po0.05 in relation to the vehicle.
nn Po0.01 in relation to the vehicle.
nnn Po0.001.
Table 2
Effects of different doses from methanolic extract of Hymenaea stigonocarpa of the bar
Methods Treatments (p.o.) Dose (mg/kg) N Gastric Lesion
Absolute Sham – 5 –
Ethano Vehicle – 12 112.48719.4
l Carbenoxolone 100 6 25.31713.22
MHs 50 6 148.36747.4
100 6 170.38747.6
150 8 23.7075.21nn
200 10 35.52713.90
NSAID Sham – 6 –
Vehicle – 8 40.12711.42
Cimetidine 100 6 1.1770.98nn
MHs 50 8 24.87710.73
100 7 20.5775.54
150 8 36.5716.69
200 8 5.5072.54nn
Results are expressed in mean7S.E.M. ANOVA followed by Dunnett’s test: gastric lesi
n Po0.05 represents difference in relation to control group treated with the vehic
nn Po0.01 represents difference in relation to control group treated with the vehic(Table 1). The decrease in the severity of the diarrhoea as
measured by the evacuation index was also observed in a group
of animals treated with 100 mg/Kg MHs or loperamide. Treatment
with MHs (100, 150 and 200 mg/Kg) before the cathartic agent
(castor oil) signiﬁcantly decreased liquid evacuation similar to the
results produced by loperamide (Po0.05).
Although the fruit pulp shows laxative effect (Brand~ao, 1993),
was not tested in this experiment, due to the difﬁculty of testing
the fruit pulp as diet in this experimental model. The antidiar-
rheal effect of MHs was not accompanied by a reduction in
intestinal transit. The effect of MHs on normal intestinal propul-
sion of mice was tested with different doses of the extract
(Table 2). In the MHs-treated group of mice, all doses of extract
did not change the normal intestinal propulsive movement
relative to the morphine group; morphine produced a greater
anti-motility effect (Po0.05).
As a part of the pharmacological study of the gastroprotective
effects of MHs, the extract was evaluated in experimental models of
gastric ulcers induced by multiple damaging agents (Table 3). Daily,
the gastric mucosa is challenged by a variety of both endogenous
and exogenous irritants (aggressive factors) including ethanol,
gastric acid, pepsin, reactive oxygen species, non-steroidal anti-
inﬂammatory drugs (NSAIDs) and Helicobacter pylori (Holzer, 1998).
In this context, treatment with anti-ulcer compounds that possess
anti-secretory, gastroprotective, spasmolytic, immunomodulatory,
antibacterial and/or anti-inﬂammatory effects seems interesting as
it may lead to the use of certain compounds with multitarget
actions, e.g., medicinal plants (Wagner, 2006). Among the differenteal induced by castor oil in mice.
n classiﬁcation Evacuation
index (EI)
Inhibitiona (%)
Semi-solid Liquid
0.0070.00 7.0071.26 21.5073.99 –
0.0070.00 0.8070.80nn 2.6072.60nn 88
2.1470.59 1.0070.30n 8.2870.97n 61
3.6670.71nn 1.0070.36n 10.8372.21 50
4.1470.85nn 0.2870.18 nnn 10.1471.79 53
and signiﬁcant differences were represented by nPo0.05, nnPo0.01, nnn Po0.001
of EI, Kruskal-Wallis followed by Dunn.
k (MHs) on models of gastric induced lesions in rats.
(mm2) Inhibition (%) GSH (nmol/g) MPO (U/g)
– 2136.347142.95nn 322.60726.58n
2 – 1583.84761.98 845.977147.53
nn 77 2032.807101.73nn 387.78795.94n
6 – 1457.937107.19 1087.487343.86
5 – 1379.18784.33 572.12781.99
79 1568.647101.00 371.96744.80n
nn 68 1855.71788.83n 481.25749.61n
– 2089.407277.49nn 323.83713.64nn
– 1098.507116.89 798.357101.76
97 1883.15768.03nn 844.37782.98
– 1233.59735.84 838.127170.03
– 1243.57783.49 1125.627115.03
– 1502.367100.39 702.6 37110.05
86 1630.127108.07n 516.60733.43n
on, GSH and MPO:
le.
le.
Table 3
Effect of methanolic extract of the bark of Hymenaea stigonocarpa (MHs) and fruit pulp of Hymenaea stigonocarpa (Hs) (10%) on biochemical parameters of toxicity in rats
submitted to the gastric lesions induced by acetic acid.
Treatments (p.o) AST (U/L) ALT (U/L) c- GT (U/L) Creatinine (mg/dL) Urea (mg/dL) glucose (mg/dL)
Sham 199.00730.20 46.5076.40 0.7070.11 05.470.04 30.0071.73 149.0074.78
Vehicle 157.14713.37 44.2872.52 0.9570.17 0.5570.01 38.1471.12 136.8577.05
lansoprazole 181.20717.50 48.0075.04 2.0270.55a 0.5670.02 39.4075.35 136.4075.80
MHs (barks) 159.12714.34 41.8772.69 1.3070.16 0.5870.03 47.1275.00 144.75711.17
Hs (fruit pulp) 166.00712.44 40.0073.24 1.1770.19 0.5570.04 32.5072.06 148.8777.24
Biochemical parameters from the different experimental groups (n¼8) after 14 days of daily treatment. Results are mean7S.E.M. AST (aspartate aminotransferase),
ALT (alanine aminotransferase), gamma-GT (gamma glutamyltransferase), creatinine, urea and glucose.
a Po0.05 represents difference in relation to sham group (Kruskall–Wallis, Dunn).
Fig. 1. Effects of methanolic extract of Hymenaea stigonocarpa (MHs) on gastric
lesions induced by ethanol in rats pretreated with L-NAME (an inhibitor of NO
synthase). The bars represent mean7S.E.M. for lesion area. The numbers indicate
the percentage protection in relation to the control group treated with vehicle.
ANOVA was employed, followed by Dunnett’s test, and signiﬁcant differences
were represented by *po0.05 and **po0.01 vs control group treated with
vehicle.
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found to be most effective at the 200 mg/Kg dose in both experi-
mental models. The gastric damage in the group treated with MHs
was signiﬁcantly decreased, by 68% in the absolute ethanol model
and 86% in the NSAID model when compared to their respective
control groups treated with vehicle (Po0.05). These gastroprotec-
tive effects of MHs in both experimental models were also accom-
panied by biochemical changes. The MHs groups demonstrated a
restoration of glutathione levels, an important marker of oxidative
damage (Bufﬁnton and Doe, 1995) in the gastric mucosa before
gastric damage was induced by ulcerogenic agents. This protective
effect in MHs groups was accompanied by a signiﬁcant reduction in
MPO activity in the group treated with 200 mg/Kg MHs. The
decrease in myeloperoxidase activity in the gastric mucosa of the
group pre-treated with MHs might be interpreted as an anti-
inﬂammatory property of a given compound (Veljaca et al., 1995).
Therefore, considering both the gastric lesion and the biochemical
parameters, MHs at 200 mg/Kg demonstrated a preventive effect
against induced damage in the gastric mucosa in the two
models used.
The next step of this study was the evaluation the effect of
MHs on gastric juice parameters of the extract by either an oral or
intraduodenal route through the pylorus ligature mode. We
evaluated the systemic effect of MHs in the pylorus ligation
model using histamine (secretagogue) and the combination of
this secretagogue with extract. The oral and intraduodenal
administration of MHs was not able to change the pH of the
gastric juice (oral route¼MHs 0.670.4 vs vehicle 1.070.6
and intraduodenal route¼MHs 1.270.1 vs histamine 1.170.1).
Therefore, the MHs did not act as an antacid or as buffer solution
in contact with gastric mucosa, as indicated by the lack of
antisecretory effects in the gastric juice. The gastric mucus is
one of the most important protective features for the gastric
mucosa, and the effect of MHs in the amount of gastric mucus was
also evaluated in pylorus-ligated rats. We observed that the
amount of adhered gastric mucus was not augmented by treat-
ment with MHs (200 mg/Kg) when compared to the animals
treated with vehicle (MHs-1350.817111.59 and vehicle-
1524.717156.69 mg/g of tissue) (data not shown). These results
rule out an increase in the amount of mucus as a potential
mechanism of action for the gastroprotective effect of MHs.
We investigated the involvement of endogenous sulphydryls in
the gastroprotective effect of MHs using NEM (N-ethylmaleimide),
a sulphydryl compound depleter (SHs). Non-protein sulphydryl
(NP-SH) compounds are important components of the gastric
mucus. NP-SH compounds exert gastroprotective effects by main-
taining the integrity of the mucosal barrier and by binding free
radicals formed due to the action of noxious agents such as ethanol
(Szabo and Vattay, 1990). The involvement of endogenous sulfhy-
dryls compounds was analysed by pretreating with NEM, and we
observed that MHs did not change the protective effect (data not
shown), eliminating another possible gastroprotective mechanism.According to Gomes et al. (2009), the absence of NP-SH involvement
and the unchanged gastric secretion parameters (as observed in
pylorus-ligated rats) strongly indicate the absence of mucus invol-
vement in MHs gastroprotection.
In addition to NP-SH, endogenous nitric oxide (NO) is impor-
tant for maintaining gastric epithelial integrity and mucus bar-
riers (Tulassay and Hersze´nyi, 2010). Previous studies indicated
the involvement of NO in the gastric protection observed experi-
mentally by promoting blood vessel dilatation and reducing
lipoperoxidation, acting similarly to an anti-inﬂammatory drug
(Ancha et al., 2003). The gastroprotective effect of MHs was
challenged with L-NAME (NG-nitro-L-arginine methyl-ester), a
nitric oxide synthase inhibitor. Pretreatment of animals L-NAME
markedly increased gastric lesions of animals treated with MHs
(Fig. 1), a group that previously had 76% inhibition of gastric
lesions. These results demonstrated the involvement of NO in the
gastroprotective effect of this extract. The known ability of NO to
decrease lipoperoxidation, act as an antioxidant and increase
vasodilation enables NO to reverse some important types of
tissue injury such as ischemia.
Ischemia/reperfusion (I/R) induced gastric lesions are linked to
free radical (FR) formation (El-Abhar et al., 2003). Ischemia
followed by reperfusion leads to tissue injury (Piper et al.,
2003). The restoration of blood ﬂow (reperfusion) after a period
of ischemia initiates a cascade of changes, including the release of
local reactive oxygen species (ROS) and an increase in the
adhesion of neutrophils to endothelial cells, which causes damage
to the integrity of the mucosal lining via free radical release
(Rastogi et al., 1998; Abdallah et al., 2009).
When the stomach was subjected to ischemia and reperfusion
(I/R), the severity of gastric lesions was signiﬁcantly increased. The
group treated with MHs displayed a signiﬁcant reduction in gastric
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to the group control saline (19.676.5 mm2) (Fig. 2). Our results
show that MHs markedly protects against gastric ulceration induced
by I/R (80%) compared to the control group treated with saline.
These effects were accompanied by an ability to maintain the GSH
content at high levels when compared to the group treated with
vehicle. Kobata et al. (2007) described a marked increase in mucosal
MPO activity in the stomach after I/R, conﬁrming the inﬁltration/
activation of neutrophils in the gastric mucosa during I/R. However,
MHs did not change the levels of MPO (Fig. 2).
Many studies have reported various mechanisms involved in
cysteamine-induced duodenal ulcers, including reduced somatos-
tatin bioavailability and elevated gastrin secretion (Seiler et al.,
1983). This model has been considered the standard model for
experimental duodenal ulcers and has been used for the biological
efﬁcacy assessment of new anti-ulcer drugs. According to
Khomenko et al. (2009), animals treated with cysteamine display
a signiﬁcant increase in duodenal lesions due to the generation of
free radicals. Fig. 3 shows that duodenal injuries caused by
cysteamine were signiﬁcantly reduced after treatment with
MHs (98%) comparing to in the group treated with vehicle. TheFig. 2. Gastroprotective activity of methanolic extract of Hymenaea stigonocarpa
(MHs) barks on levels of total glutathione and myeloperoxidase on model of
gastric injury induced by ischemia/ reperfusion in rats (n¼8–10).The bars
represented as mean7S.E.M. for lesion area. The numbers indicate the percentage
protection in relation to the control group treated with vehicle. ANOVA was
employed, followed by Dunnett’s test and signiﬁcant differences were represented
by p*o0.05 for lesion area, #po0.05 and po0.01## for total glutathione,
þpo0.05 for myeloperoxidase vs control group treated with vehicle.
Fig. 3. Effect of methanolic extract of Hymenaea stigonocarpa (MHs) on lesion area,
level of total glutathione and myeloperoxidase on model of duodenal injury
induced by cysteamine in rats (n¼8). The bars represented as mean7S.E.M for
lesion area. The numbers indicate the percentage protection in relation to the
control group treated with vehicle. ANOVA was employed, followed by Dunnett’s
test, and signiﬁcant differences were represented by **po0.01 for lesion area,
#po0.05 and po0.01## for total glutathione and þpo0.05 and þ þpo0.01 for
myeloperoxidase vs control group treated with vehicle.glutathione (GSH) levels and myeloperoxidase activity (MPO) in
the duodenum of experimental animals are also shown in Fig. 3.
The role of GSH in gastric mucosa in counteracting free radical
production has been extensively reported (Townsend et al., 2003).
Our results reveal the duodenal damage in the saline control
group to be biochemically characterised by a 7-fold increase in
duodenal MPO activity and by signiﬁcant duodenal GSH depletion
when compared to sham, both consequences of the oxidative
stress that takes place in the damaging process. Although animals
treated with MHs demonstrated the same MPO activity as that
exhibited by the saline control group, the extract prevented the
depletion of GSH (2171.687129.75 nmol/g of tissue) that
occurred in the saline control group (1381.36763.85 nmol/g of
tissue) (Fig. 3). Glutathione is essential in controlling the redox
state in the cell via several mechanisms including the scavenging
of reactive oxygen species and the maintenance of glutathione
peroxidase enzymatic levels in a reduced state (Sies, 1999). Thus,
the duodenal and gastric protective effects of MHs may be
mediated by its antioxidant properties. This property of MHs
was also observed in the antioxidant activity assay, in which MHs
had an IC50 value of 5.2570.23 mg/mL. The corresponding IC50
value of quercetin was 0.3370.01 mg/mL.
The cicatrisation assay was performed using the acetic acid
method, which, according to Okabe and Amagase (2005), most
closely approximates human gastric ulcers. New drugs that
prevent ulcer relapse and enhance ulcer healing could potentially
be developed using this established method. Based on the use of
bark in folk medicine against gastric ulcers and also the practice
of consuming the fruit pulp of this species as food, we evaluated
the healing activity of MHs and diet with fruit pulp in the healing
ulcer model induced by acetic acid. Thus, this study determined
the effect of MHs (200 mg/Kg) and diet with fruit pulp Hs (10%)
during 7 or 14 consecutive days on the healing of gastric (Fig. 4)
and duodenal ulcers (Fig. 5) induced by acetic acid in rats. After
7 days of treatment to the gastric mucosa, MHs and lansoprazole
improved ulcer healing by shrinking the size of the lesion area
compared to the vehicle (53% and 83%, respectively). In the
groups treated with lansoprazole and diet with fruit pulp Hs,
there was a signiﬁcant maintenance of glutathione levels (Fig. 4).
After the 14-day MHs treatment, lansoprazole and diet with fruit
pulp were able to heal gastric ulcers by decreasing the lesion area
(83%, 60% and 61%, respectively) in relation to the control group
treated with vehicle. However, only treatment with lansoprazole
prevented depletion of glutathione (Fig. 4). Fig. 5 shows that
lansoprazole and diet with fruit pulp were effective in healingFig. 4. Gastric healing effect of methanolic extract of Hymenaea stigonocarpa
(MHs) and fruit pulp by treatment during 7 or 14 days after injury induced by
acetic acid in rats (n¼8). The bars represented as mean7S.E.M. for lesion area.
The numbers indicate the percentage protection in comparison to the control
group treated with vehicle. ANOVA was employed, followed by Dunnett’s test, and
signiﬁcant differences were represented by *Po0.05, **Po0.01 for lesion area;
þ þpo0.01 for total glutathione vs control group treated with vehicle.
Fig. 5. Duodenal healing effect of methanolic extract of Hymenaea stigonocarpa
(MHs) and fruit pulp by treatment during 7 or 14 days after injury induced by
acetic acid in rats (n¼8). The bars represented as mean7S.E.M. for lesion area.
The numbers indicate the percentage protection in comparison to the control
group treated with vehicle. ANOVA was employed, followed by Dunnett’s test, and
signiﬁcant differences were represented by *Po0.05, **Po0.01 for lesion area;
þpo0.05, þ þpo0.01 for total glutathione vs control group treated with vehicle.
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vehicle (61% and 71%, respectively). However, the results in Fig. 5
show that only treatment with lansoprazole for 14 consecutive
days was able to reduce the duodenal ulcers (72%). The results in
Fig. 5 also demonstrate that treatment with MHs and diet with
fruit pulp was able to prevent depletion of glutathione in healing
duodenal ulcers within 7 or 14 consecutive days of treatment
compared to the control group treated with vehicle. Taken
together, these results reinforce the marked effect of MHs and
also of diet with fruit pulp in inhibiting gastric and duodenal
lesions and in promoting the healing of chronic gastric and
duodenal ulcers in rats.
Toxicity analysis performed in the cicatrisation model (14 day)
did not show any toxic effects from the MHs and diet with fruit
pulp, and no behaviour changes were observed during treatment.
The body weight of the animals progressed similarly in all groups,
and there was no signiﬁcant different in the organ weights
between groups. Biochemical analysis of AST (unspeciﬁc marker
of hepatic damage), ALT (speciﬁc marker of hepatic parenchymal
damage), gamma-GT (initial indicator of hepatic toxicity), creati-
nine, glucose and urea (markers of renal damage) in the serum of
the animals treated for 14 consecutive days with MHs or diet with
fruit pulp did not reveal any alterations (Table 3), indicating that
during the treatment period neither substance demonstrated any
signs of toxicity.
The HPLC-PAD ﬁngerprints of H.stigonocarpa bark and fruit
pulp are qualitatively similar, given their phenolic composition
(Fig. 6A), conﬁrming the manifest polyphenolic nature of both
extracts. Peaks eluted in the retention time (Rt) ranging from 0 to
26 min showed a week band approximately 280 nm, a shoulder
near 220 nm and a maximum absorption between 205 and
210 nm (Fig. 6B) typical of catechin derivatives (Fig. 6C) (Rohr
et al., 2000). In the Rt region of 26–34 min a second group of
compounds was eluted that exhibited maximum absorption
bands near 216 and 270 nm (Fig. 6D) suggestive of gallic acid
derivatives (dag) (Fig. 6E) (Rohr et al., 2000). Moreover, the poorly
resolved peak eluted at Rt¼39–48 min with a UV pattern char-
acteristic of catechins is closely related to polymeric catechins.
The chromatographic proﬁle obtained by HPLC-PAD analysis of
H. stigonocarpa bark and fruit pulp led to the recognition of
ﬂavonoids and condensed tannins.
The qualitative phytochemical screening tests demonstrated
that fruits and barks of H stigonocarpa are composed primarilyof phenolic compounds such as ﬂavonoids and condensed
tannins. The antioxidant activities of the ﬂavonoids and tannins,
phytochemical compounds present in MHs, are most likely
responsible for these results. Previous studies have highlighted
the role of ﬂavonoids in a spectrum of biological activities
including anti-ulcer and free radical scavenging (Wach et al.,
2007; Havsteen, 2002). The phytochemical composition of MHs
(ﬂavonoids) is most likely involved in this result because a study
by Rao and Vijayakumar (2007) has already described (þ)-catechin,
the ﬂavonoid present in MHs, to be an important gastroprotective
compound against gastric mucosal injury induced by ischemia–
reperfusion in rats. According toMoreira et al. (2004), the antioxidant
capacity of the ﬂavonoids has therapeutic potential for treating
gastric and duodenal diseases. Tannins are potent scavengers of
peroxyl radicals and can also interact with mucus proteins, improv-
ing their cytoprotective effect by forming a protein lining over the
gastrointestinal mucosa (Okuda, 2005).
However, a central role for NO in the gastroprotective effect of
MHs extract may also explain MHs’ ability to protect against I/R.
Systemic nitrite reduction is greatly enhanced during hypoxic/
ischemic conditions (Lundberg and Weitzberg, 2010). Several
studies in animal models of ischemia and reperfusion indicate
that nitrite and nitrate can modulate hypoxic signalling. Admin-
istration of nitrite and nitrate protects against ischemia–
reperfusion injury in gastric ulcers (Lundberg and Weitzberg,
2010). Hence, the antioxidant activity and the involvement of
NO may be among the most important defensive factors involved
in the anti-ulcerogenic effects of MHs.
Extracts prepared from bark of the Hymenaea courbaril
(jatoba´), a medicinal plant from the same genus, contain many
bioactive compounds such as procyanidins (Sasaki et al. (2009)).
Procyanidins (condensed tannins), a subclass of ﬂavonoids, are
widely distributed in a variety of plant species (Santos-Buelga and
Scalbert, 2000). Procyanidins have been reported to exhibit a
variety of biological activities, including strong antioxidative or
free radical scavenging effects (Takahata et al., 2001). Indeed,
the fruit protective effect is most likely mediated by diverse
nutrients, including antioxidant vitamins, minerals, phytochem-
icals, and ﬁbre, among others (Marin et al., 2009). Zayachkivska
et al. (2005) demonstrated polyphenolic substances to have
anti-inﬂammatory activity in the gastrointestinal tract (GIT),
promoting tissue repair though the expression of several growth
factors, antioxidant activity and the scavenging of reactive oxygen
species (ROS).
The gastroprotective and cicatrising effects of MHs and diet with
fruit pulp on peptic ulcers observed in this study can be attributed to
the presence of tannins and ﬂavonoids in H. stigonocarpa given the
antioxidant effects of this species. Thus, to explore new compounds
with antioxidant properties from medicinal plants is important,
since most of the synthetic drugs available on the market to treat
peptic ulcers produces many undesirable side effects, when used
long term.4. Conclusions
Based on these data, we conclude that the methanolic extract
of Hymenaea stigonocarpa bark (MHs) has antidiarrheal, gastro-
protective and cicatrising activities, and the diet with pulp fruits
also demonstrate healing effects. The protective action of the
extract against various ulcerogenic agents is related to the
involvement of NO. The gastroprotective effect of the extract
was accompanied by prevention of GSH depletion and inhibition
of myeloperoxidase activity in gastric and duodenal mucosa.
These observed effects can be attributed to the antioxidant effect
due to the presence of condensed tannins and ﬂavonoids in the
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Fig. 6. HPLC-PAD ﬁngerprints of H. stigonocarpa barks and pulp fruits (A). UV spectrum pattern derivatives catechin (dc) (B), compounds identiﬁed as dc (C), UV spectrum
pattern derivatives gallic acid (dga) (D) and compounds identifﬁed as dga. Phenomenex Synergi Hydro column (C18, 2504.6 mm d. i., 4 mm). Eluent A: H2Oþ0.1% TFA;
eluent B: ACNþ0.1% TFA. Ranging from 10 to 23% of B in 35 min, 23–90% of B in 50 min at a ﬂow rate of 1 ml min1. l¼254 nm.
P. Rodrigues Orsi et al. / Journal of Ethnopharmacology 143 (2012) 81–90 89bark and fruit of H. stigonocarpa. The cicatrising action of MHs
(7 and 14 days) and diet with fruit pulp (14 days) in gastric ulcers
and diet with fruit pulp (7 days) in duodenal ulcers demonstrated
the powerful healing effect of both the extract and the diet with
fruit pulp. Our ﬁndings suggest that the fruit pulp of H. stigonocarpa
may represent an important dietary source for the treatment of
peptic ulcers.Acknowledgements
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